4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Optimization of Follow-up of Patients With Symptomatic Recent Osteoporotic Vertebral Fracture (OPTIVERT)

Optimization of Follow-up of Patients With Symptomatic Recent Osteoporotic Vertebral Fracture (OPTIVERT)

Study Description
Brief Summary:

The management of osteoporotic fractures has recently changed with the emergence of new programs dedicated to the diagnosis and treatment of osteoporosis. For example, the Fracture Network of the Paris Saint-Joseph Hospital Group, created in 2015, identifies and ensures the care of patients who have consulted emergency rooms for osteoporotic fractures. Within this sector, the vertebral fracture (VF) appears to be the most frequent (22.4%) ahead of other fracture sites, confirming the results of other studies that consider VF as a real public health problem.

Osteoporotic vertebral fractures (OVF) have certain specificities compared to other osteoporotic fractures, encouraging particular interest.


Condition or disease Intervention/treatment Phase
Osteoporotic Fractures Procedure: Life quality evaluation Not Applicable

Detailed Description:

A. Particularities of OVF management

  • Pain intensity caused by OVF justifies specific analgesic management. Analgesic management is sometimes complicated by co-morbidities and patients age, with poor analgesics tolerance, in particular opioids.
  • OVF is responsible for a change in patients' quality of life, often with a loss of autonomy.
  • VF is considered as severe fracture that warrants anti-osteoporotic drug therapy (if osteoporotic origin has been confirmed), in order to avoid risk of a new osteoporotic fracture.
  • Progressive profil of pain associated with OVF and importance vertebral extent collapse may justify the use of specific "vertebral augmentation" procedures on vertebra, such as cementoplasty or kyphoplasty. These interventions are aimed at disappearance / reduction of pain related to OVF, improvement of life quality or correction or elimination of a static spinal disorder related to fracture.

B. Current rheumatology OVF management at the GHPSJ Patients management with OVF can be either outpatient or inpatient, depending on the extent of pain, fracture context, and co-morbidities.

- Rheumatology department of the GHPSJ has set up an outpatient patient path dedicated to osteoporotic vertebral fracture, making it possible to optimize patients concerned management. This route has follow characteristics : Patients with OVF are seen by rheumatologist during a consultation dedicated to OVF (Vertebral Fracture Consultation), and benefit the same day from spinal radiographs, bone densitometry and a biological assessment of fragile osteopathy on the GHPSJ site. During consultation, fracture history, risk factors for falls, bone history, an assessment of the patient's pain, functional abilities and life quality are performed. A spinal orthosis can be made if necessary.

Then patients are seen again 15 days later by the same rheumatologist with all results of the assessment During this 2nd consultation, depending on results of the additional examinations and patient's clinical progress, analgesic treatment is adapted. In addition, anti-osteoporotic treatment may be prescribed.

  • For patients with OVF requiring hospital management in the rheumatology department, additional examinations are also carried out with the same anamnestic and clinical elements as for the above-mentioned outpatient management. Nevertheless, intensity of pain may initially prevent certain additional examinations, such as bone densitometry, from being carried out, which in this case are deferred until the patient's state of health allows them.
  • During outpatient or inpatient journey, depending on results of additional examinations and patient's clinical progress, intervention therapy can be decided and carried out as soon as possible (cementoplasty). Patients for whom cementoplasty is performed are hyperalgia patients with rapid loss of autonomy due to vertebral fracture and a general condition compatible with general anesthesia. Following cementoplasty, patients are seen again in consultation for 1 month for a clinical examination.
Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Optimization of Follow-up of Patients With Symptomatic Recent Osteoporotic Vertebral Fracture
Actual Study Start Date : January 8, 2019
Estimated Primary Completion Date : January 8, 2021
Estimated Study Completion Date : July 16, 2023
Arms and Interventions
Arm Intervention/treatment
Experimental: Life quality evaluation

Patients consulting the Emergency Department (SAU) or the rheumatology department of the GHPSJ (referred by a colleague orthopaedic surgeon, rheumatologist, radiologist or other) for a recent symptomatic osteoporotic dorsal or lumbar vertebral fracture, are called for a rheumatology consultation, vertebral fracture consultation.

Patients consulting in the rheumatology department during a spinal fracture consultation at the GHPSJ as well as patients hospitalized in the rheumatology department at the GHPSJ are selected consecutively.

- Arm 1 (intervention): two additional consultations with the rheumatology

Procedure: Life quality evaluation
As part of this research, 2 additional consultations at 12 months and 24 months will be carried out by one of the rheumatologists in the department. At the consultation 12 months after his inclusion, the patient will have a clinical examination, a quality of life questionnaire to complete and additional images (x-rays). For the 24-month consultation, the patient will have a clinical examination, a quality of life questionnaire to complete and the patient may have an additional X-ray of the spine if there is height loss > 2 cm and/or pain.

Outcome Measures
Primary Outcome Measures :
  1. Assess life quality of patients with osteoporotic VF 12 months after symptomatic vertebral fracture diagnosis: Quality of life questionnaires (QUALEFFO-41) [ Time Frame: 1 year ]
    Quality of life questionnaires (QUALEFFO-41)


Secondary Outcome Measures :
  1. Assess pain related to vertebral fracture at D0, M12 and M24 after diagnosis: Analogical visual scale [ Time Frame: Day 0 - 1 year - 2 years ]
    Analogical visual scale on the pain and taking painkillers (yes/no)

  2. Assess life quality: Quality of life questionnaires (QUALEFFO-41) [ Time Frame: 2 years ]
    Quality of life questionnaires (QUALEFFO-41)

  3. Measurement of the walking perimeter [ Time Frame: Day 0 - 1 year - 2 years ]
    the maximum distance that the person can travel without stopping (in meters)

  4. Number of new osteoporotic fractures (vertebral or nonvertebral) [ Time Frame: 1 year - 2 years ]
    Fractures that have been confirmed by an imaging examination (X-ray, +- MRI or CT)

  5. Number of new fall(s) [ Time Frame: 1 year - 2 years ]
  6. Number of hospitalizations for all causes [ Time Frame: 1 year - 2 years ]
  7. Spinal statics [ Time Frame: 1 year - 2 years ]
    Height in centimeters

  8. Management of osteoporosis [ Time Frame: 1 year - 2 years ]
    prescription completed (yes/no) antiosteoporotic treatment taken (yes/no)

  9. Analogical visual scale of patient satisfaction [ Time Frame: 1 year - 2 years ]
    (scale of 0 to 10) following the information meeting with a nurse on osteoporosis


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient > 18 years old
  • Patient consulting or hospitalized in the rheumatology department at the GHPSJ for recent and symptomatic osteoporotic spinal or lumbar fracture Recentness is defined either by anamnestic event existence (example: fall) to date the fracture less than 4 months old, or by MRI or CT signs existence of attesting to recent nature of the fracture: hypersignal T2 stir & hyposignal T1 on MRI, presence of a cleft on the CT, on imaging less than 4 months old.

Symptomatic is defined as spinal pain existence in relation to the vertebral fracture, not attributable to any cause other than the fracture.

  • Patient affiliated to a health insurance plan
  • Patient capable of giving free, informed and express consent

Exclusion Criteria:

  • Patient with fractures occurring on metastatic spine
  • Patient with unstable VF, requiring rapid orthopedic management
  • Patient with a history of cementoplasty on dorsal or lumbar spine
  • Patients transferred to another hospital after transition to SAU
  • Homeless patient
  • Patient not residing in Ile-de-France
  • Patient who is bedridden or has one or more severe co-morbidity(s) that puts fractured osteoporosis in background
  • Patient deprived of liberty
  • Patient under guardianship or curators
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Agnès PORTIER, MD 01 44 12 69 56 ext +33 aporter@hpsj.fr
Contact: Gérald RAJZBAUM, MD 01 44 12 78 06 ext + 33 grajzbaum@hpsj.fr

Locations
Layout table for location information
France
Groupe Hospitalier Paris Saint Joseph Recruiting
Paris, Ile-de-France, France, 75014
Contact: BEAUSSIER Hélène, PhD, PharmD    +33 1 44 12 70 38    hbeaussier@hpsj.fr   
Contact: CRC    +33 1 44 12 70 33    crc@hpsj.fr   
Sponsors and Collaborators
Groupe Hospitalier Paris Saint Joseph
Investigators
Layout table for investigator information
Principal Investigator: Agnès PORTIER, MD Groupe Hospitalier Paris Saint Joseph
Tracking Information
First Submitted Date  ICMJE May 27, 2019
First Posted Date  ICMJE May 30, 2019
Last Update Posted Date March 9, 2020
Actual Study Start Date  ICMJE January 8, 2019
Estimated Primary Completion Date January 8, 2021   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: May 29, 2019)
Assess life quality of patients with osteoporotic VF 12 months after symptomatic vertebral fracture diagnosis: Quality of life questionnaires (QUALEFFO-41) [ Time Frame: 1 year ]
Quality of life questionnaires (QUALEFFO-41)
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: May 29, 2019)
  • Assess pain related to vertebral fracture at D0, M12 and M24 after diagnosis: Analogical visual scale [ Time Frame: Day 0 - 1 year - 2 years ]
    Analogical visual scale on the pain and taking painkillers (yes/no)
  • Assess life quality: Quality of life questionnaires (QUALEFFO-41) [ Time Frame: 2 years ]
    Quality of life questionnaires (QUALEFFO-41)
  • Measurement of the walking perimeter [ Time Frame: Day 0 - 1 year - 2 years ]
    the maximum distance that the person can travel without stopping (in meters)
  • Number of new osteoporotic fractures (vertebral or nonvertebral) [ Time Frame: 1 year - 2 years ]
    Fractures that have been confirmed by an imaging examination (X-ray, +- MRI or CT)
  • Number of new fall(s) [ Time Frame: 1 year - 2 years ]
  • Number of hospitalizations for all causes [ Time Frame: 1 year - 2 years ]
  • Spinal statics [ Time Frame: 1 year - 2 years ]
    Height in centimeters
  • Management of osteoporosis [ Time Frame: 1 year - 2 years ]
    prescription completed (yes/no) antiosteoporotic treatment taken (yes/no)
  • Analogical visual scale of patient satisfaction [ Time Frame: 1 year - 2 years ]
    (scale of 0 to 10) following the information meeting with a nurse on osteoporosis
Original Secondary Outcome Measures  ICMJE
 (submitted: May 29, 2019)
  • Assess pain related to vertebral fracture at D0, M12 and M24 after diagnosis: Analogical visual scale [ Time Frame: Day 0 - 1 year - 2 years ]
    Analogical visual scale on the pain and taking painkillers (yes/no)
  • Assess life quality: Quality of life questionnaires (QUALEFFO-41) [ Time Frame: 2 years ]
    Quality of life questionnaires (QUALEFFO-41)
  • Measurement of the walking perimeter [ Time Frame: Day 0 - 1 year - 2 years ]
    the maximum distance that the person can travel without stopping (in meters)
  • Number of new osteoporotic fractures (vertebral or nonvertebral) [ Time Frame: 1 year - 2 years ]
    Fractures that have been confirmed by an imaging examination (X-ray, +- MRI or CT)
  • Number of new fall(s) [ Time Frame: 1 year - 2 years ]
  • Number of hospitalizations for all causes [ Time Frame: 1 year - 2 years ]
  • Spinal statics [ Time Frame: 1 year - 2 years ]
    Heigt in centimeters
  • Management of osteoporosis [ Time Frame: 1 year - 2 years ]
    prescription completed (yes/no) antiosteoporotic treatment taken (yes/no)
  • Analogical visual scale of patient satisfaction [ Time Frame: 1 year - 2 years ]
    (scale of 0 to 10) following the information meeting with a nurse on osteoporosis
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Optimization of Follow-up of Patients With Symptomatic Recent Osteoporotic Vertebral Fracture
Official Title  ICMJE Optimization of Follow-up of Patients With Symptomatic Recent Osteoporotic Vertebral Fracture
Brief Summary

The management of osteoporotic fractures has recently changed with the emergence of new programs dedicated to the diagnosis and treatment of osteoporosis. For example, the Fracture Network of the Paris Saint-Joseph Hospital Group, created in 2015, identifies and ensures the care of patients who have consulted emergency rooms for osteoporotic fractures. Within this sector, the vertebral fracture (VF) appears to be the most frequent (22.4%) ahead of other fracture sites, confirming the results of other studies that consider VF as a real public health problem.

Osteoporotic vertebral fractures (OVF) have certain specificities compared to other osteoporotic fractures, encouraging particular interest.

Detailed Description

A. Particularities of OVF management

  • Pain intensity caused by OVF justifies specific analgesic management. Analgesic management is sometimes complicated by co-morbidities and patients age, with poor analgesics tolerance, in particular opioids.
  • OVF is responsible for a change in patients' quality of life, often with a loss of autonomy.
  • VF is considered as severe fracture that warrants anti-osteoporotic drug therapy (if osteoporotic origin has been confirmed), in order to avoid risk of a new osteoporotic fracture.
  • Progressive profil of pain associated with OVF and importance vertebral extent collapse may justify the use of specific "vertebral augmentation" procedures on vertebra, such as cementoplasty or kyphoplasty. These interventions are aimed at disappearance / reduction of pain related to OVF, improvement of life quality or correction or elimination of a static spinal disorder related to fracture.

B. Current rheumatology OVF management at the GHPSJ Patients management with OVF can be either outpatient or inpatient, depending on the extent of pain, fracture context, and co-morbidities.

- Rheumatology department of the GHPSJ has set up an outpatient patient path dedicated to osteoporotic vertebral fracture, making it possible to optimize patients concerned management. This route has follow characteristics : Patients with OVF are seen by rheumatologist during a consultation dedicated to OVF (Vertebral Fracture Consultation), and benefit the same day from spinal radiographs, bone densitometry and a biological assessment of fragile osteopathy on the GHPSJ site. During consultation, fracture history, risk factors for falls, bone history, an assessment of the patient's pain, functional abilities and life quality are performed. A spinal orthosis can be made if necessary.

Then patients are seen again 15 days later by the same rheumatologist with all results of the assessment During this 2nd consultation, depending on results of the additional examinations and patient's clinical progress, analgesic treatment is adapted. In addition, anti-osteoporotic treatment may be prescribed.

  • For patients with OVF requiring hospital management in the rheumatology department, additional examinations are also carried out with the same anamnestic and clinical elements as for the above-mentioned outpatient management. Nevertheless, intensity of pain may initially prevent certain additional examinations, such as bone densitometry, from being carried out, which in this case are deferred until the patient's state of health allows them.
  • During outpatient or inpatient journey, depending on results of additional examinations and patient's clinical progress, intervention therapy can be decided and carried out as soon as possible (cementoplasty). Patients for whom cementoplasty is performed are hyperalgia patients with rapid loss of autonomy due to vertebral fracture and a general condition compatible with general anesthesia. Following cementoplasty, patients are seen again in consultation for 1 month for a clinical examination.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Condition  ICMJE Osteoporotic Fractures
Intervention  ICMJE Procedure: Life quality evaluation
As part of this research, 2 additional consultations at 12 months and 24 months will be carried out by one of the rheumatologists in the department. At the consultation 12 months after his inclusion, the patient will have a clinical examination, a quality of life questionnaire to complete and additional images (x-rays). For the 24-month consultation, the patient will have a clinical examination, a quality of life questionnaire to complete and the patient may have an additional X-ray of the spine if there is height loss > 2 cm and/or pain.
Study Arms  ICMJE Experimental: Life quality evaluation

Patients consulting the Emergency Department (SAU) or the rheumatology department of the GHPSJ (referred by a colleague orthopaedic surgeon, rheumatologist, radiologist or other) for a recent symptomatic osteoporotic dorsal or lumbar vertebral fracture, are called for a rheumatology consultation, vertebral fracture consultation.

Patients consulting in the rheumatology department during a spinal fracture consultation at the GHPSJ as well as patients hospitalized in the rheumatology department at the GHPSJ are selected consecutively.

- Arm 1 (intervention): two additional consultations with the rheumatology

Intervention: Procedure: Life quality evaluation
Publications *
  • Ballane G, Cauley JA, Luckey MM, El-Hajj Fuleihan G. Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int. 2017 May;28(5):1531-1542. doi: 10.1007/s00198-017-3909-3. Epub 2017 Feb 6. Review.
  • Venmans A, Lohle PN, van Rooij WJ. Pain course in conservatively treated patients with back pain and a VCF on the spine radiograph (VERTOS III). Skeletal Radiol. 2014 Jan;43(1):13-8. doi: 10.1007/s00256-013-1729-x. Epub 2013 Oct 8.
  • Jung HJ, Park YS, Seo HY, Lee JC, An KC, Kim JH, Shin BJ, Kang TW, Park SY. Quality of Life in Patients with Osteoporotic Vertebral Compression Fractures. J Bone Metab. 2017 Aug;24(3):187-196. doi: 10.11005/jbm.2017.24.3.187. Epub 2017 Aug 31.
  • Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O, Kanis JA, Liberman U, Minne H, Reeve J, Reginster JY, de Vernejoul MC, Wiklund I. Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis. Osteoporos Int. 1997;7(1):36-8.
  • Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, Stracke H, Seeman E. Risk of new vertebral fracture in the year following a fracture. JAMA. 2001 Jan 17;285(3):320-3.
  • Li L, Ren J, Liu J, Wang H, Wang X, Liu Z, Sun T. Results of Vertebral Augmentation Treatment for Patients of Painful Osteoporotic Vertebral Compression Fractures: A Meta-Analysis of Eight Randomized Controlled Trials. PLoS One. 2015 Sep 17;10(9):e0138126. doi: 10.1371/journal.pone.0138126. eCollection 2015.
  • Carlier RY, Gordji H, Mompoint DM, Vernhet N, Feydy A, Vallée C. Osteoporotic vertebral collapse: percutaneous vertebroplasty and local kyphosis correction. Radiology. 2004 Dec;233(3):891-8. Epub 2004 Oct 14.
  • Tsoumakidou G, Too CW, Koch G, Caudrelier J, Cazzato RL, Garnon J, Gangi A. CIRSE Guidelines on Percutaneous Vertebral Augmentation. Cardiovasc Intervent Radiol. 2017 Mar;40(3):331-342. doi: 10.1007/s00270-017-1574-8. Epub 2017 Jan 19.
  • Ibrahim A, Singh DKA, Shahar S. 'Timed Up and Go' test: Age, gender and cognitive impairment stratified normative values of older adults. PLoS One. 2017 Oct 3;12(10):e0185641. doi: 10.1371/journal.pone.0185641. eCollection 2017.
  • Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993 Sep;8(9):1137-48.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Recruiting
Estimated Enrollment  ICMJE
 (submitted: May 29, 2019)
100
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE July 16, 2023
Estimated Primary Completion Date January 8, 2021   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Patient > 18 years old
  • Patient consulting or hospitalized in the rheumatology department at the GHPSJ for recent and symptomatic osteoporotic spinal or lumbar fracture Recentness is defined either by anamnestic event existence (example: fall) to date the fracture less than 4 months old, or by MRI or CT signs existence of attesting to recent nature of the fracture: hypersignal T2 stir & hyposignal T1 on MRI, presence of a cleft on the CT, on imaging less than 4 months old.

Symptomatic is defined as spinal pain existence in relation to the vertebral fracture, not attributable to any cause other than the fracture.

  • Patient affiliated to a health insurance plan
  • Patient capable of giving free, informed and express consent

Exclusion Criteria:

  • Patient with fractures occurring on metastatic spine
  • Patient with unstable VF, requiring rapid orthopedic management
  • Patient with a history of cementoplasty on dorsal or lumbar spine
  • Patients transferred to another hospital after transition to SAU
  • Homeless patient
  • Patient not residing in Ile-de-France
  • Patient who is bedridden or has one or more severe co-morbidity(s) that puts fractured osteoporosis in background
  • Patient deprived of liberty
  • Patient under guardianship or curators
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE
Contact: Agnès PORTIER, MD 01 44 12 69 56 ext +33 aporter@hpsj.fr
Contact: Gérald RAJZBAUM, MD 01 44 12 78 06 ext + 33 grajzbaum@hpsj.fr
Listed Location Countries  ICMJE France
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03967704
Other Study ID Numbers  ICMJE OPTIVERT
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE Not Provided
Responsible Party Groupe Hospitalier Paris Saint Joseph
Study Sponsor  ICMJE Groupe Hospitalier Paris Saint Joseph
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Principal Investigator: Agnès PORTIER, MD Groupe Hospitalier Paris Saint Joseph
PRS Account Groupe Hospitalier Paris Saint Joseph
Verification Date March 2020

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP